Clinical trial NCT05427994: Assessing the Quality of Life and Social Support in Age-Related Macular Degeneration Patients
Official title: Assessing the Quality of Life and Social Support in Age-Related Macular Degeneration Patients
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Age-Related Macular Degeneration
Keywords: age-related macular degeneration
quality of life
social support
reliability of social support
vision related quality of life
Lead sponsor: Asfendiyarov Kazakh National Medical University
Sponsor class: OTHER
First posted: 2022-06-22
Enrollment: 458
Sex: ALL
Minimum age (years): 30
Maximum age (years): 90
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: Patients with diagnosed age-related macular degeneration

Brief summary: The aim of this study is to evaluate the quality of life of AMD patients related to vision using the short version of the National Eye Institute Visual Function Questionnaire (NEI-VFQ-25), patients' social support, and their relationship with demographic and clinical variables.

Detailed description: Background and study aims. Age-related macular degeneration (AMD) is the most prevalent chronic progressive ocular disease. It has been shown in several studies that AMD affects the quality of life of patients. The aim of this study is to evaluate the quality of life of AMD patients related to vision using the short version of the National Eye Institute Visual Function Questionnaire (NEI-VFQ-25), patients' social support, and their relationship with demographic and clinical variables.

Who can participate? Patients with AMD, who wish to participate, will be recruited. Patients will be recruited from three locations of the Kazakh Scientific - Research Institute of Eye Diseases in Almaty, Nur-Sultan and Shymkent.

What does the study involve? The study involves collecting demographic data of the participants, collecting baseline visual testing data from medical records, filling out of the NEI-VFQ-25, and answering two yes/no questions related to the social support and reliability of social support.

What are possible benefits and risks of participating? Assessment of quality of life and social support of the AMD patients is a first step of developing targeted psycho-social support programs for AMD patients.

Where is the study run from? Patients will be recruited from three locations of the Kazakh Scientific - Research Institute of Eye Diseases in Almaty, Nur-Sultan and Shymkent.

When is the study starting and how long it is expected to run for? Start date 03/02/2020. End date 27/08/2022.

Who is funding the study? No funding for this study. Who is the main contact? Principal investigator: Inara Ismailova; +380 73 200 0688; i.ismayilova@gmail.com

Eligibility criteria: Inclusion Criteria:

* age-related macular degeneration; ability to speak and understand Russian and/or Kazakh language; willingness to participate

Exclusion Criteria:

* Presence of glaucoma, cataracts of grade 2 or more according to the Lens Opacities Classification System (LOCS) III, and the presence of corneal opacities or any other retinal diseases

Primary outcomes:
measure: Quality of life of AMD patients
timeFrame: at the recruitment to the study
Secondary outcomes:
measure: Social Support
timeFrame: at the recruitment to the study
measure: Reliability of Social Support
timeFrame: at the recruitment to the study
measure: Relationship between QOL and social support
timeFrame: at the recruitment to the study
Other outcomes:
Locations:
city: Almaty
country: Kazakhstan
facility: Kazakh Scientific - Research Institute of Eye Diseases
city: Astana
country: Kazakhstan
facility: Medical Centre Hospital of President'S Affairs Administration of the Republic of Kazakhstan
Study officials:
affiliation: Asfendiyarov Kazakh National Medical University
name: Inara Isamyilova, PhD
role: PRINCIPAL_INVESTIGATOR
References: